PENINGKATAN KADAR NITRIC OXIDE DAN OSTEOKALSIN PADA TIKUS SPRAGUE DAWLEY YANG DIBERI ASAM LEMAK TRANS DOSIS TINGGI - Diponegoro University | Institutional Repository (UNDIP-IR)
DAFTAR PUSTAKA
1. Baziad A (1), 2003. Menopause dan Andropause. 1st ed. Jakarta: Yayasan Bina
Pustaka Sarwono Prawirohardjo.
2. Djokomoeljanto R, 2003. Postmenopausal osteoporosis. Patofisiologi dan dasar
pengobatan. Simposium Osteoporosis Postmenopausal. Semarang: p.1-12.
3. Raisz LG, 2005. Pathogenesis of osteoporosis concepts, conflicts and prospects.
J.Clin Invest; 115 (12): p. 3318-25.
4. Sartika RAD. Pengaruh Asupan Asam Lemak Trans terhadap Profil Lipid Darah
(Disertasi ). Program Doktor Ilmu Epidemiologi Program Pasca Sarjana Fakultas
Kesehatan Masyarakat Universitas Indonesia 2007.
5. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C et
al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J
Clin Nutr 2003: 78;370-5.
6. US Departemen of Health and Human Services, Food and Drug Administration
2003.
7. Chatgilialoglu C, Ferreri C, Lykakis IN, wardman P. Tran- Fatty acids dan radical
stress: What are the real culprits? J.bmc.2006.50-2.
8. Griendling KK, FitzGerald. Ovidative Stres and cardiovasculer injuri. Part I: basic
mechanism and in Vivo Monitoring of ROS. Circulation 2003;108:1912-16. Gong
D, Yang R, Munir KM, Horenstein RB, Shuldiner AR. New Progress in
Adipocytokine Research. Curr Opin in Endo & Diab 2003; 10: 115-21.
9. McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics
and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific.
2003. p.883-5.
10. Szmitko PE, wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New
Markers of Inflamation and Endothelial Cell Activation: Part I. Circulation 2003;
108:1917-23.
11. Rob J. Van’t Hof, Stuart H. Ralston. Nitric Oxide and Bone. Blackwell Science Ltd.
Immunology 2001; 103:255-261.
xxii
12. Ganero P, Delmas PD, 2004. Contribution of bone mineral density and bone
turnover markers to the estimation of risk of osteoporotic fracture in post
menopausal women. Musculoskel Neuron Interact. 4(1): p.50-63.
13. Ott SM., 1999. Osteoporosis and Osteomalacia in Principles of Geriatric Medicine
and Gerontology. 4th Ed., New York, Mc. Graw Hill: p. 1057–83.
14. Allison J L, Hodges S, Eastell R, 2000. Measurement of osteocalcin in Ann Clin
Biochem, Review Article (37): p. 432-46.
15. Kaniawati, M., Moeliandari, F, 2003, Penanda Biokimia untuk Osteoporosis. Forum
Diagnosticum Prodia Diagnostics Educational Services. No 1: hal. 1–18.
16. Hammett, Stabler CA, 2004. Osteoporosis from pathophysiology to treatment. In:
Washington American Assosiation for Clinical Chemistry Press.p. 1-86.
17. Filip RS, Zagorski, 2004. Age and BMD-Related Difference in Biochemical Markers
of Bone Metabolism in Rural and Urban Women from Lublin Region, Poland. Ann
Agric Environ med. (11): p.255-59.
18. Dorfman SE, Laurent D, Gounarides JS, Li Xue, Mullarkey TL., Rocheford EC.
Metabolic Implication of Dietary Trans- fatty Acids.
Obesity journal
org.2009;17,6:1200-07.
19. Roberts WL, sedrick R, Moulton L, Spencer A, Rifai N, Evaluation of Four
Automated high- Sensitivity C-Reactive protein methods; Implications for Clinical
and epidemiological applications. Clinical chemistry 2000;46/4:461-8.
20. Mozaffarian D, Katan MB, Ascherio A, Stampfer M, Willett WC. Trans Fatty Acids
and Cardiovasculer Disease. N Engl J Med 2006;354:1601-13.
21. Bensadoun A. Trans fatty Acids- Health and labeling Issues. Food an Nutrition. Ask
the Nutrition Expert in Food and Nutrition. Cornell Cooperative Extension. Cornell
University 2003.
22. Brehm BJ. Trans- Fatty Acids : Coming Soon to Your Food Labels. In Diet and
Nutrition. University of Cincinnaty 2003.
23. Inis SM. The Trans Fatty Acid Composition and Content of Canadian Foods in Child
and Family Research Institute Nutrition Research Program. University of British
Columbia. JADA 2001.
24. O’Brien RD. Fats and Oils Processing for Aplications.
1998 p. 81- 95.
xxiii
Technomic. Lancaster.
25. Martin JC, Nour M, Lavillonniere F, Sebedio JL. Effect of Fatty Acid Positional
Distribution and Triacylglycerol Composition on Lipid By- Products Formation
During Heat Treatment : II. Trans Isomers, J Am Oil Chem Soc. 1998: 75 (9):
1073-78.
26. Judd JT, Clevidence BA. Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary
Trans Fatty Acids: Effects on Plasma Lipids and Lipoproteins of Healthy Men and
Women. Am J Clin Nutr. 1994: 59:861-68.
27. Sebedio JL, Chardigny JM. Physiological Effects of Trans and Cyclic Fatty Acids, In
Perkins EG,
Srickson. Deep Frying; Chemistry, Nutrition, and Practical
Applications, AOCS Press. Campaign, Illinois.1996 p 181-209.
28. Bhagavan NV. Medical Biochemistry 4th ed. IAP Harcourt Academic Press. San
Diego 2002. p. 388.
29. Wardlaw GM, Hampl JS, DiSilvestro RA. Lipids in Perspectives in Nutrition. 6th
ed. Mc Graw Hill Boston 2004: 177- 210.
30. Murray, RK, Granner DK, Mayes PA, Rodwell VW. Biokimia Harper Edisi 25.
EGC. 2005.
31. Oomen CM, Ocke MC, Feskens EJM, Kok FJ, van Erp- Baart MAJ, Kok FJ, et al.
Association between Trans Fatty Acids Intake and 10 Year Risk of Coronary Heart
Disease in the Zulphen Elderly Study: a Prospective Population Based Study.
Lancet 2001: 357: 746- 51.
32. Beynen AC, Katan MB. Impact of Dietary Cholesterol and Fatty Acids on Serum
Lipids and Lipoproteins in Man. Academic Press Limited. Netherlands. 1989:p.
238- 256.
33. Dietschy JM. Dietary Fatty Acids and the Regulation of Plasma Low Density
Lipoprotein Cholesterol Concentrations. American Society for Nutritional Sciences.
The Journal of Nutrition.1998;128;2:444S-8S.
34. Chandrasekharan N, Basiron Y 2000. Palm Oil in human nutrition and health.
Planter. 2000: 76(890);299-312.
35. Subbaiah PV, Subramanian VS, and Liu M. Trans Unsaturated Fatty Acids Inhibit
Lecithin: Cholesterol Acyltransferase and Alter its Positional Pecifity. J Lipid Res.
1998. 39: 1438- 47.
xxiv
36. Turpeinen AM, Wubert J, Aro A, Lorenz R, Mutanen M. Similar Effects of Diets
Rich in Stearic Acid or trans- Fatty Acids on Platelet Function and Stearic Acid or
Trans- Fatty Acids on Platelet Function and Endothelial Prostacyclin Production in
Humans.. Aterioscler. Thromb Vasc Biol. 1998;18:316-322.
37. Nicolosi RJ,
Wilson TS, Lawton C, Handelman GJ. Dietary Effects on
Cardiovascular Disease Risk Factors: Beyond Saturated Fatty Acids and
Cholesterol. J Am Coll Nutr 2001; 20: 5,4128-427.
38. Madge LA. Pober JS. TNF signaling in vasculer endothelial cells. Exp Mol Pathol
2001;70:317-25.
39. Muller H. SeljeflotI. Solvoii K. Pedersen JL. Partially hydrogeneted soybean oil
reduces posprandial t- PA activity compared with palm oil. Atherosclerosis
2001:155:467-76.
40. Isbagio H,. 2005. dalam : Panduan Diagnosis dan Pengelolaan Osteoporosis.
Pengurus Besar Ikatan Rematologi Indonesia (IRA): hal. 1-31.
41. McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics
and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific.
2003. p.883-5.
42. Chandalia M, Cabo Chan AV, Sridevi D, Jialal I, Grundy SM, and Abate N.
Elevated plasma high Sensitgivity C-eacvtive Protein Concentration in Asdia Indians
Living in the United states. The Journal of Clinical Endocrrinology & Metabolism
Vol 88,377- 9.
43. Buckwalter JA, Glinicher MJ, Cooper RR, Recher R. Bone biology. J.Bone Joint
Surg.1995; 77(8): p.1256-72.
44. Riis BJ. The role of bone turnover in pathophysiology of osteoporosis. Br J Obstet
Gynecol. 1996;103 (13): p. 9-15.
45. Lane NE. Lebih lengkap tentang osteoporosis rapuh tulang 1st ed. Jakarta:
RajaGrafindo Persada. 2001.
46. Rachman IA. Osteoporosis primer (Post menopause osteoporosis). In: Osteoporosis.
edisi I. Editor: Suherman SK, Tobing S Dohar AL. Perhimpunan Osteoporosis
Indonesia. Indomedika.2006; p. 1-16.
47. Compston JE. Sex Steroid and Bone. In: Physiological reviews. The american
physiology society. 2001; p. 419-46.
xxv
48. Morgan SL, Saag KG, Julian BA, Blair H. Osteopenic bone disease. Arthritis and
allied condition 14th ed. Editors: Koopman WJ. Philadelphia. Lippincott Williams
and Wilkins. (122).2001; p. 2449-97.
49. Rosenberg AE. Bones, joints and soft tissue tumors. In: Kumar V, Abbas AK, Fausto
N, editors. Robbins and Contran Pathologic Basic of Disease 8th ed. Philadelphia:
Elseiver Saunders. 2005;(26) ; p. 1273-83.
50. Hoffbrand A.V, Pettit J.E. Essential Haematology; alih bahasa, Iyan Darmawan.
Ed.2. EGC Penerbit Buku Kedokteran. Jakarta. 1996;hal. 180-5.
51. Drajad RS. Struktur dan fungsi skeleton. In: Kursus dasar metabolism kalsium dan
penyakit tulang. Editors. Soeatmadji DJokoW, Rudijanto A, Arsana PM.
PERKENI,Malang. 2002;(III): p.1-9.
52. Van Essen HW, Holzmann PJ, Blankenstein MA, Lips P, Bravenboer N,2007. Effect
of Raloxifene Treatment on Osteocyte Apoptosis in Post Menopausal Women. Calsif
Tissue Int.(81): p. 183-90.
53. Canalis E. The Fate of Circulating Osteoblast. N Engl J Med. 2005; (35)2: p. 19.
54. Soeatmadji Djoko W. Kendali hormonal metabolisme calsium dan skeletal. In:
Kursus dasar metabolisme kalsium dan penyakit tulang. Editors. Soeatmadji Djoko
W, Rudijanto A, Arsana PM. PERKENI, Malang. 2002;(IV)1-17.
55. Eder K, Schleser S, Becker K, Korting R. Conyugated Linoleic Acids Lower the
Release of Eicosanods and Nitric Oxide from Human Aortic Endothelial cells. J.
Nutr. 2003,133:4083-9.
56. Cantor WJ. Early cardiac chathetrization is associated with lower mortality only
among high rusk patient TS and non TS elevation acut coronary syndromes:
observations from the OPUS- TIMI 16 trial, Am Heart J 149(2);2005:275-83.
57. Ivaska K. Osteocalcin. Novel insights into the use of osteocalcin as a determinant of
bone metabolism. Department of Anatomy, Institute ofBiomedicine, University of
Turku, Turku, Finland, and The National Graduate School for Musculoskeletal
Diseases (TULES) University of Turku, Finland. Clin Chem: 2005,p.1-113.
58. Soekidjo N. Metode Penelitian Eksperimen. Dalam Metode Penelitian Kesehatan.
Rineka Cipta. 2010: 50-9.
59. Cantatore FP, Crivellato E, Nico B, Ribatti D. Osteocalcin is angiogenic in vivo.
Cell Biol Int. 2005; 29:583-85.
xxvi
60. Taylor A.F. Osteoblastic glutamate receptor function regulates bone formation and
resorption. J Musculoskel Neuron Interact. 2002; 2(3):285-90.
61. Van’t H., Ralston S. Nitric oxide and bone. Immunology 2001;103:255-261.
62. Neve A., Corrado A., Paolo F. Osteoblast physiology in normal and pathological
conditions. Cell Tissue Res. Springer-Verlag. 2010.
xxvii
1. Baziad A (1), 2003. Menopause dan Andropause. 1st ed. Jakarta: Yayasan Bina
Pustaka Sarwono Prawirohardjo.
2. Djokomoeljanto R, 2003. Postmenopausal osteoporosis. Patofisiologi dan dasar
pengobatan. Simposium Osteoporosis Postmenopausal. Semarang: p.1-12.
3. Raisz LG, 2005. Pathogenesis of osteoporosis concepts, conflicts and prospects.
J.Clin Invest; 115 (12): p. 3318-25.
4. Sartika RAD. Pengaruh Asupan Asam Lemak Trans terhadap Profil Lipid Darah
(Disertasi ). Program Doktor Ilmu Epidemiologi Program Pasca Sarjana Fakultas
Kesehatan Masyarakat Universitas Indonesia 2007.
5. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C et
al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J
Clin Nutr 2003: 78;370-5.
6. US Departemen of Health and Human Services, Food and Drug Administration
2003.
7. Chatgilialoglu C, Ferreri C, Lykakis IN, wardman P. Tran- Fatty acids dan radical
stress: What are the real culprits? J.bmc.2006.50-2.
8. Griendling KK, FitzGerald. Ovidative Stres and cardiovasculer injuri. Part I: basic
mechanism and in Vivo Monitoring of ROS. Circulation 2003;108:1912-16. Gong
D, Yang R, Munir KM, Horenstein RB, Shuldiner AR. New Progress in
Adipocytokine Research. Curr Opin in Endo & Diab 2003; 10: 115-21.
9. McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics
and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific.
2003. p.883-5.
10. Szmitko PE, wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New
Markers of Inflamation and Endothelial Cell Activation: Part I. Circulation 2003;
108:1917-23.
11. Rob J. Van’t Hof, Stuart H. Ralston. Nitric Oxide and Bone. Blackwell Science Ltd.
Immunology 2001; 103:255-261.
xxii
12. Ganero P, Delmas PD, 2004. Contribution of bone mineral density and bone
turnover markers to the estimation of risk of osteoporotic fracture in post
menopausal women. Musculoskel Neuron Interact. 4(1): p.50-63.
13. Ott SM., 1999. Osteoporosis and Osteomalacia in Principles of Geriatric Medicine
and Gerontology. 4th Ed., New York, Mc. Graw Hill: p. 1057–83.
14. Allison J L, Hodges S, Eastell R, 2000. Measurement of osteocalcin in Ann Clin
Biochem, Review Article (37): p. 432-46.
15. Kaniawati, M., Moeliandari, F, 2003, Penanda Biokimia untuk Osteoporosis. Forum
Diagnosticum Prodia Diagnostics Educational Services. No 1: hal. 1–18.
16. Hammett, Stabler CA, 2004. Osteoporosis from pathophysiology to treatment. In:
Washington American Assosiation for Clinical Chemistry Press.p. 1-86.
17. Filip RS, Zagorski, 2004. Age and BMD-Related Difference in Biochemical Markers
of Bone Metabolism in Rural and Urban Women from Lublin Region, Poland. Ann
Agric Environ med. (11): p.255-59.
18. Dorfman SE, Laurent D, Gounarides JS, Li Xue, Mullarkey TL., Rocheford EC.
Metabolic Implication of Dietary Trans- fatty Acids.
Obesity journal
org.2009;17,6:1200-07.
19. Roberts WL, sedrick R, Moulton L, Spencer A, Rifai N, Evaluation of Four
Automated high- Sensitivity C-Reactive protein methods; Implications for Clinical
and epidemiological applications. Clinical chemistry 2000;46/4:461-8.
20. Mozaffarian D, Katan MB, Ascherio A, Stampfer M, Willett WC. Trans Fatty Acids
and Cardiovasculer Disease. N Engl J Med 2006;354:1601-13.
21. Bensadoun A. Trans fatty Acids- Health and labeling Issues. Food an Nutrition. Ask
the Nutrition Expert in Food and Nutrition. Cornell Cooperative Extension. Cornell
University 2003.
22. Brehm BJ. Trans- Fatty Acids : Coming Soon to Your Food Labels. In Diet and
Nutrition. University of Cincinnaty 2003.
23. Inis SM. The Trans Fatty Acid Composition and Content of Canadian Foods in Child
and Family Research Institute Nutrition Research Program. University of British
Columbia. JADA 2001.
24. O’Brien RD. Fats and Oils Processing for Aplications.
1998 p. 81- 95.
xxiii
Technomic. Lancaster.
25. Martin JC, Nour M, Lavillonniere F, Sebedio JL. Effect of Fatty Acid Positional
Distribution and Triacylglycerol Composition on Lipid By- Products Formation
During Heat Treatment : II. Trans Isomers, J Am Oil Chem Soc. 1998: 75 (9):
1073-78.
26. Judd JT, Clevidence BA. Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary
Trans Fatty Acids: Effects on Plasma Lipids and Lipoproteins of Healthy Men and
Women. Am J Clin Nutr. 1994: 59:861-68.
27. Sebedio JL, Chardigny JM. Physiological Effects of Trans and Cyclic Fatty Acids, In
Perkins EG,
Srickson. Deep Frying; Chemistry, Nutrition, and Practical
Applications, AOCS Press. Campaign, Illinois.1996 p 181-209.
28. Bhagavan NV. Medical Biochemistry 4th ed. IAP Harcourt Academic Press. San
Diego 2002. p. 388.
29. Wardlaw GM, Hampl JS, DiSilvestro RA. Lipids in Perspectives in Nutrition. 6th
ed. Mc Graw Hill Boston 2004: 177- 210.
30. Murray, RK, Granner DK, Mayes PA, Rodwell VW. Biokimia Harper Edisi 25.
EGC. 2005.
31. Oomen CM, Ocke MC, Feskens EJM, Kok FJ, van Erp- Baart MAJ, Kok FJ, et al.
Association between Trans Fatty Acids Intake and 10 Year Risk of Coronary Heart
Disease in the Zulphen Elderly Study: a Prospective Population Based Study.
Lancet 2001: 357: 746- 51.
32. Beynen AC, Katan MB. Impact of Dietary Cholesterol and Fatty Acids on Serum
Lipids and Lipoproteins in Man. Academic Press Limited. Netherlands. 1989:p.
238- 256.
33. Dietschy JM. Dietary Fatty Acids and the Regulation of Plasma Low Density
Lipoprotein Cholesterol Concentrations. American Society for Nutritional Sciences.
The Journal of Nutrition.1998;128;2:444S-8S.
34. Chandrasekharan N, Basiron Y 2000. Palm Oil in human nutrition and health.
Planter. 2000: 76(890);299-312.
35. Subbaiah PV, Subramanian VS, and Liu M. Trans Unsaturated Fatty Acids Inhibit
Lecithin: Cholesterol Acyltransferase and Alter its Positional Pecifity. J Lipid Res.
1998. 39: 1438- 47.
xxiv
36. Turpeinen AM, Wubert J, Aro A, Lorenz R, Mutanen M. Similar Effects of Diets
Rich in Stearic Acid or trans- Fatty Acids on Platelet Function and Stearic Acid or
Trans- Fatty Acids on Platelet Function and Endothelial Prostacyclin Production in
Humans.. Aterioscler. Thromb Vasc Biol. 1998;18:316-322.
37. Nicolosi RJ,
Wilson TS, Lawton C, Handelman GJ. Dietary Effects on
Cardiovascular Disease Risk Factors: Beyond Saturated Fatty Acids and
Cholesterol. J Am Coll Nutr 2001; 20: 5,4128-427.
38. Madge LA. Pober JS. TNF signaling in vasculer endothelial cells. Exp Mol Pathol
2001;70:317-25.
39. Muller H. SeljeflotI. Solvoii K. Pedersen JL. Partially hydrogeneted soybean oil
reduces posprandial t- PA activity compared with palm oil. Atherosclerosis
2001:155:467-76.
40. Isbagio H,. 2005. dalam : Panduan Diagnosis dan Pengelolaan Osteoporosis.
Pengurus Besar Ikatan Rematologi Indonesia (IRA): hal. 1-31.
41. McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics
and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific.
2003. p.883-5.
42. Chandalia M, Cabo Chan AV, Sridevi D, Jialal I, Grundy SM, and Abate N.
Elevated plasma high Sensitgivity C-eacvtive Protein Concentration in Asdia Indians
Living in the United states. The Journal of Clinical Endocrrinology & Metabolism
Vol 88,377- 9.
43. Buckwalter JA, Glinicher MJ, Cooper RR, Recher R. Bone biology. J.Bone Joint
Surg.1995; 77(8): p.1256-72.
44. Riis BJ. The role of bone turnover in pathophysiology of osteoporosis. Br J Obstet
Gynecol. 1996;103 (13): p. 9-15.
45. Lane NE. Lebih lengkap tentang osteoporosis rapuh tulang 1st ed. Jakarta:
RajaGrafindo Persada. 2001.
46. Rachman IA. Osteoporosis primer (Post menopause osteoporosis). In: Osteoporosis.
edisi I. Editor: Suherman SK, Tobing S Dohar AL. Perhimpunan Osteoporosis
Indonesia. Indomedika.2006; p. 1-16.
47. Compston JE. Sex Steroid and Bone. In: Physiological reviews. The american
physiology society. 2001; p. 419-46.
xxv
48. Morgan SL, Saag KG, Julian BA, Blair H. Osteopenic bone disease. Arthritis and
allied condition 14th ed. Editors: Koopman WJ. Philadelphia. Lippincott Williams
and Wilkins. (122).2001; p. 2449-97.
49. Rosenberg AE. Bones, joints and soft tissue tumors. In: Kumar V, Abbas AK, Fausto
N, editors. Robbins and Contran Pathologic Basic of Disease 8th ed. Philadelphia:
Elseiver Saunders. 2005;(26) ; p. 1273-83.
50. Hoffbrand A.V, Pettit J.E. Essential Haematology; alih bahasa, Iyan Darmawan.
Ed.2. EGC Penerbit Buku Kedokteran. Jakarta. 1996;hal. 180-5.
51. Drajad RS. Struktur dan fungsi skeleton. In: Kursus dasar metabolism kalsium dan
penyakit tulang. Editors. Soeatmadji DJokoW, Rudijanto A, Arsana PM.
PERKENI,Malang. 2002;(III): p.1-9.
52. Van Essen HW, Holzmann PJ, Blankenstein MA, Lips P, Bravenboer N,2007. Effect
of Raloxifene Treatment on Osteocyte Apoptosis in Post Menopausal Women. Calsif
Tissue Int.(81): p. 183-90.
53. Canalis E. The Fate of Circulating Osteoblast. N Engl J Med. 2005; (35)2: p. 19.
54. Soeatmadji Djoko W. Kendali hormonal metabolisme calsium dan skeletal. In:
Kursus dasar metabolisme kalsium dan penyakit tulang. Editors. Soeatmadji Djoko
W, Rudijanto A, Arsana PM. PERKENI, Malang. 2002;(IV)1-17.
55. Eder K, Schleser S, Becker K, Korting R. Conyugated Linoleic Acids Lower the
Release of Eicosanods and Nitric Oxide from Human Aortic Endothelial cells. J.
Nutr. 2003,133:4083-9.
56. Cantor WJ. Early cardiac chathetrization is associated with lower mortality only
among high rusk patient TS and non TS elevation acut coronary syndromes:
observations from the OPUS- TIMI 16 trial, Am Heart J 149(2);2005:275-83.
57. Ivaska K. Osteocalcin. Novel insights into the use of osteocalcin as a determinant of
bone metabolism. Department of Anatomy, Institute ofBiomedicine, University of
Turku, Turku, Finland, and The National Graduate School for Musculoskeletal
Diseases (TULES) University of Turku, Finland. Clin Chem: 2005,p.1-113.
58. Soekidjo N. Metode Penelitian Eksperimen. Dalam Metode Penelitian Kesehatan.
Rineka Cipta. 2010: 50-9.
59. Cantatore FP, Crivellato E, Nico B, Ribatti D. Osteocalcin is angiogenic in vivo.
Cell Biol Int. 2005; 29:583-85.
xxvi
60. Taylor A.F. Osteoblastic glutamate receptor function regulates bone formation and
resorption. J Musculoskel Neuron Interact. 2002; 2(3):285-90.
61. Van’t H., Ralston S. Nitric oxide and bone. Immunology 2001;103:255-261.
62. Neve A., Corrado A., Paolo F. Osteoblast physiology in normal and pathological
conditions. Cell Tissue Res. Springer-Verlag. 2010.
xxvii